Prudo-Chlebosz Raymond → Akari Therapeutics Plc AKTX

Stake: 9.30% Shares: 4,926,600,800 CUSIP: 00972G207 Class: Ordinary Shares, $0.0001 par value

Item 4 — Purpose of Transaction

On December 2, 2024, Dr. Prudo purchased the securities described in the November 2024 Private Placement as described in Item 3 above.

Insider Activity (last 365d)

3 transactions

0 buys · 0 sales · 3 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 1.00

16,430 shares short · -8.7% vs prior

+1 day

-6.7%

+5 days

-29.6%

+30 days

-55.7%

+60 days

-45.7%

+90 days

-46.6%

+180 days

-37.2%

Anchor price 89.20 on closest trading day on/after 2024-11-14. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Date	Insider	Role	Type	Shares	Price	Value
2026-07-07	Patel Samir Rashmikant	director, 10%+ owner	Option exercise	1,209	$8.00	$10K
2026-07-07	Patel Samir Rashmikant	director, 10%+ owner	Option exercise	15,466	$0.00	$6
2026-07-07	Patel Samir Rashmikant	director, 10%+ owner	Option exercise	5,799	$0.00	$2

Filed	Form	Filer	Stake	Shares
2026-06-08	SCHEDULE 13G	MMCAP International Inc. SPC	—	—	view →
2024-01-04	SC	RPC Pharma Ltd	—	—	view →
2022-01-14	SC	RPC Pharma Ltd	—	—	view →
2021-10-18	SC	RPC Pharma Ltd	—	—	view →
2020-03-30	SC	RPC Pharma Ltd	—	—	view →

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.